CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Net sales	$ 37,442,000,000	$ 34,717,000,000	$ 33,009,000,000
Costs, expenses and other
Cost of products and services sold	23,613,000,000	21,360,000,000	20,637,000,000
Research and development expenses	1,812,000,000	1,454,000,000	1,375,000,000
Selling, general and administrative expenses	5,450,000,000	5,235,000,000	4,887,000,000
Impairment of goodwill	724,000,000	0	0
Impairment of assets held for sale	270,000,000	219,000,000	0
Other (income) expense	(1,247,000,000)	(843,000,000)	(830,000,000)
Interest and other financial charges	1,344,000,000	1,048,000,000	749,000,000
Total costs, expenses and other	31,966,000,000	28,473,000,000	26,818,000,000
Income from continuing operations before taxes	5,476,000,000	6,244,000,000	6,191,000,000
Tax expense	1,008,000,000	1,249,000,000	1,262,000,000
Net income from continuing operations	4,468,000,000	4,995,000,000	4,929,000,000
Net income from discontinued operations	304,000,000	745,000,000	743,000,000
Net income	4,772,000,000	5,740,000,000	5,672,000,000
Less: Net income attributable to noncontrolling interest	43,000,000	35,000,000	14,000,000
Net income attributable to Honeywell	$ 4,729,000,000	$ 5,705,000,000	$ 5,658,000,000
Earnings per share of common stock—basic:
Earnings per share of common stock from continuing operations - basic (in dollars per share)	$ 6.98	$ 7.63	$ 7.41
Earnings per share of common stock from discontinued operations - basic (in dollars per share)	0.42	1.13	1.12
Total earnings per share of common stock—basic (in dollars per share)	7.40	8.76	8.53
Earnings per share of common stock—assuming dilution:
Earnings per share of common stock from continuing operations - assuming dilution (in dollars per share)	6.94	7.58	7.36
Earnings per share of common stock from discontinued operations - assuming dilution (in dollars per share)	0.42	1.13	1.11
Total earnings per share of common stock—assuming dilution (in dollars per share)	$ 7.36	$ 8.71	$ 8.47
Product
Net sales	$ 24,515,000,000	$ 22,841,000,000	$ 22,345,000,000
Costs, expenses and other
Cost of products and services sold	16,153,000,000	15,017,000,000	14,836,000,000
Service
Net sales	12,927,000,000	11,876,000,000	10,664,000,000
Costs, expenses and other
Cost of products and services sold	$ 7,460,000,000	$ 6,343,000,000	$ 5,801,000,000

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 4,772,000,000	$ 5,740,000,000	$ 5,672,000,000
Net income from discontinued operations	304,000,000	745,000,000	743,000,000
Net income from continuing operations	4,468,000,000	4,995,000,000	4,929,000,000
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities
Depreciation	546,000,000	493,000,000	490,000,000
Amortization	842,000,000	659,000,000	514,000,000
Loss (gain) on sale of non-strategic businesses and assets	18,000,000	1,000,000	(5,000,000)
Impairment of goodwill	724,000,000	0	0
Impairment of assets held for sale	270,000,000	219,000,000	0
Repositioning and other (gains) charges	(167,000,000)	239,000,000	844,000,000
Net payments for repositioning and other charges	(378,000,000)	(470,000,000)	(445,000,000)
NARCO Buyout payment	0	0	(1,325,000,000)
Resideo indemnification and reimbursement agreement termination payment	1,590,000,000	0	0
Asbestos liabilities divestiture payment	(1,428,000,000)	0	0
Pension and other postretirement income	(396,000,000)	(477,000,000)	(408,000,000)
Pension and other postretirement benefit payments	(20,000,000)	(32,000,000)	(35,000,000)
Stock compensation expense	196,000,000	189,000,000	197,000,000
Deferred income taxes	18,000,000	(229,000,000)	189,000,000
Other	144,000,000	(191,000,000)	(534,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures
Accounts receivable	(825,000,000)	(129,000,000)	67,000,000
Inventories	(636,000,000)	(286,000,000)	(549,000,000)
Other current assets	(233,000,000)	(111,000,000)	224,000,000
Accounts payable	724,000,000	78,000,000	444,000,000
Accrued liabilities	1,325,000,000	233,000,000	270,000,000
Income taxes	(707,000,000)	(69,000,000)	(408,000,000)
Net cash provided by operating activities from continuing operations	6,075,000,000	5,112,000,000	4,459,000,000
Net cash provided by operating activities from discontinued operations	333,000,000	985,000,000	881,000,000
Net cash provided by operating activities	6,408,000,000	6,097,000,000	5,340,000,000
Cash flows from investing activities
Capital expenditures	(986,000,000)	(871,000,000)	(741,000,000)
Proceeds from disposals of property, plant and equipment	31,000,000	0	43,000,000
Increase in investments	(1,503,000,000)	(1,077,000,000)	(560,000,000)
Decrease in investments	1,469,000,000	870,000,000	971,000,000
(Payments) receipts from settlements of derivative contracts	(399,000,000)	94,000,000	6,000,000
Cash paid for acquisitions, net of cash acquired	(2,211,000,000)	(8,880,000,000)	(718,000,000)
Proceeds from sales of businesses, net of fees paid	1,157,000,000	0	4,000,000
Net cash used for investing activities from continuing operations	(2,442,000,000)	(9,864,000,000)	(995,000,000)
Net cash used for investing activities from discontinued operations	(269,000,000)	(293,000,000)	(298,000,000)
Net cash used for investing activities	(2,711,000,000)	(10,157,000,000)	(1,293,000,000)
Cash flows from financing activities
Proceeds from issuance of commercial paper and other short-term borrowings	24,297,000,000	13,838,000,000	12,991,000,000
Payments of commercial paper and other short-term borrowings	(22,815,000,000)	(11,578,000,000)	(13,663,000,000)
Proceeds from issuance of common stock	237,000,000	537,000,000	196,000,000
Proceeds from issuance of long-term debt	4,035,000,000	10,408,000,000	2,986,000,000
Payments of long-term debt	(2,909,000,000)	(1,812,000,000)	(1,731,000,000)
Repurchases of common stock	(3,804,000,000)	(1,655,000,000)	(3,715,000,000)
Cash dividends paid	(2,976,000,000)	(2,902,000,000)	(2,855,000,000)
Pre-separation funding	1,962,000,000	0	0
Spin-off cash	(449,000,000)	0	0
Other	469,000,000	3,000,000	28,000,000
Net cash (used for) provided by financing activities	(1,953,000,000)	6,839,000,000	(5,763,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	176,000,000	(137,000,000)	14,000,000
Net increase (decrease) in cash and cash equivalents	1,920,000,000	2,642,000,000	(1,702,000,000)
Cash and cash equivalents at beginning of period	10,567,000,000	7,925,000,000	9,627,000,000
Cash and cash equivalents at end of period	$ 12,487,000,000	$ 10,567,000,000	$ 7,925,000,000

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 12,487	$ 9,906
Short-term investments	443	386
Accounts receivable, less allowances of $202 and $307, respectively	7,621	7,247
Inventories	6,162	5,884
Assets held for sale	2,492	1,365
Other current assets	1,182	1,259
Current assets of discontinued operations	0	1,861
Total current assets	30,387	27,908
Investments and long-term receivables	1,404	1,230
Property, plant and equipment—net	4,629	4,457
Goodwill	21,079	21,019
Other intangible assets—net	6,736	6,621
Deferred income taxes	199	235
Other assets	9,247	10,556
Assets of discontinued operations	0	3,170
Total assets	73,681	75,196
Current liabilities
Accounts payable	6,315	6,109
Commercial paper and other short-term borrowings	5,893	4,273
Current maturities of long-term debt	1,546	1,325
Accrued liabilities	8,462	8,055
Total current liabilities	23,414	21,256
Long-term debt	27,141	25,440
Deferred income taxes	1,577	1,581
Postretirement benefit obligations other than pensions	111	112
Asbestos-related liabilities	0	1,325
Other liabilities	6,408	5,581
Liabilities of discontinued operations	0	740
Redeemable noncontrolling interest	0	7
SHAREOWNERS’ EQUITY
Capital—common stock issued	958	958
Capital - additional paid in capital	10,157	9,695
Common stock held in treasury, at cost	(43,029)	(39,378)
Accumulated other comprehensive loss	(5,146)	(3,491)
Retained earnings	50,964	50,835
Total Honeywell shareowners’ equity	13,904	18,619
Noncontrolling interest	1,126	535
Total shareowners’ equity	15,030	19,154
Total liabilities, redeemable noncontrolling interest and shareowners’ equity	73,681	75,196
Discontinued Operations
Current liabilities
Current liabilities of discontinued operations/Liabilities held for sale	0	1,086
Disposal Group, Held-for-Sale, Not Discontinued Operations
Current liabilities
Current liabilities of discontinued operations/Liabilities held for sale	$ 1,198	$ 408